Laboratory of Molecular and Cellular Neuroscience, The Rockefeller University, New York, NY 10065, USA.
EMBO J. 2010 Aug 18;29(16):2813-26. doi: 10.1038/emboj.2010.154. Epub 2010 Jul 27.
Of the five mammalian muscarinic acetylcholine (ACh) receptors, M(5) is the only subtype expressed in midbrain dopaminergic neurons, where it functions to potentiate dopamine release. We have identified a direct physical interaction between M(5) and the AP-3 adaptor complex regulator AGAP1. This interaction was specific with regard to muscarinic receptor (MR) and AGAP subtypes, and mediated the binding of AP-3 to M(5). Interaction with AGAP1 and activity of AP-3 were required for the endocytic recycling of M(5) in neurons, the lack of which resulted in the downregulation of cell surface receptor density after sustained receptor stimulation. The elimination of AP-3 or abrogation of AGAP1-M(5) interaction in vivo decreased the magnitude of presynaptic M(5)-mediated dopamine release potentiation in the striatum. Our study argues for the presence of a previously unknown receptor-recycling pathway that may underlie mechanisms of G-protein-coupled receptor (GPCR) homeostasis. These results also suggest a novel therapeutic target for the treatment of dopaminergic dysfunction.
在五种哺乳动物毒蕈碱型乙酰胆碱 (ACh) 受体中,M(5) 是唯一在中脑多巴胺能神经元中表达的亚型,它的功能是增强多巴胺的释放。我们已经确定了 M(5) 和 AP-3 衔接复合物调节剂 AGAP1 之间的直接物理相互作用。这种相互作用在毒蕈碱受体 (MR) 和 AGAP 亚型方面是特异性的,并介导了 AP-3 与 M(5) 的结合。与 AGAP1 的相互作用和 AP-3 的活性是神经元中 M(5) 内吞循环所必需的,缺乏这些会导致细胞表面受体密度在持续受体刺激后下调。体内消除 AP-3 或破坏 AGAP1-M(5) 相互作用会降低纹状体中突触前 M(5) 介导的多巴胺释放增强的幅度。我们的研究证明了一种以前未知的受体循环途径的存在,该途径可能是 G 蛋白偶联受体 (GPCR) 内稳态机制的基础。这些结果还为治疗多巴胺能功能障碍提供了一个新的治疗靶点。